|
With over 30 years of scientific research and biopharmaceutical development experience Dr. Williams has spent the last fourteen years dedicated to the regulatory process for biological products from both U.S. and worldwide perspectives. Most recently he served as Vice President of Clinical and Regulatory Affairs and as Chief Operating Officer for Opexa Pharmaceuticals Inc. Prior corporate positions include Senior Vice President Regulatory Affairs and Operations for OSIRIS Therapeutics Inc. Vice President US Regulatory Affairs for Powderject Vaccines Assistant Vice President Worldwide Regulatory Affairs for Wyeth BioPharma and as Executive Director Regulatory Affairs for Aventis Pasteur. Dr. Williams retired as Captain from the U.S. Public Health Service with over twenty years of service in human-use product development which included assignments with the FDA Center for Biologics Evaluation and Research as a Director Scientist in the Division of Vaccine and Related Product Applications; the US Army Medical Research Institute of Infectious Diseases and the National Institutes of Health National Institutes of Allergy and Infectious Diseases as Chief Intracellular Pathogens branch; and at the U.S. Naval Medical Research Institute as a research microbiologist. He has an extensive research and development background with over 130 publications and four books in the areas of infectious diseases vaccinology and oncology. He received his B.S. degree in animal science M.S. degree in genetics and Ph.D. degree in biochemistry from Texas A&M University.
| 